Natco Pharma Board Approves INR 1,300 Crore Rights Issue
Natco Pharma approves a INR 1,300 crore rights issue to raise funds from eligible equity shareholders, subject to applicable regulatory and statutory approvals.
SEBI | 15/09/2026 | By News Bureau
Mankind Pharma files DRHP with SEBI
The company’s initial public offering comprises an offer for the sale of 40,058,884 equity shares of face value Rs 1
SEBI | 19/09/2022 | By Sudeep Soparkar | 854
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy